BioSpace News Archive

Press Releases

Multiple Ivonescimab Data Sets from Phase III Studies in Advanced NSCLC Patient Populations to be Featured at ELCC 2026

March 27, 2026
·
12 min read
Press Releases

Adagio Medical Reports Fourth Quarter and Full Year 2025 Results

March 27, 2026
·
9 min read
Press Releases

Secretome Therapeutics Announces Participation in Upcoming Investor Conferences - March 27, 2026

March 27, 2026
·
1 min read
Press Releases

Neural Therapeutics Announces Amendment to SIO Agreement, Concurrent Financing Terms, Shareholder Meeting Date and RSU Grant

March 27, 2026
·
6 min read
Press Releases

New Day Diagnostics Highlights Rising Early-Onset Colorectal Cancer Rates During Colorectal Cancer Awareness Month

March 27, 2026
·
1 min read
Press Releases

OS Therapies Granted Meetings with U.S. FDA, U.K. MHRA, EMA and Australian Therapeutic Goods Administration to Review Global Confirmatory Phase 3 Trial for OST-HER2 in Metastatic Osteosarcoma

• Meetings with all four regulatory agencies scheduled to occur in the second quarter of 2026, with expected Phase 3 commencement in the third quarter of 2026 initially in Australia • Commencing the Phase 3 confirmatory study is a pre-requisite to being granted a Biologics License Application (BLA) under the Accelerated Approval Program in the U.S. and Conditional Marketing Authorisations (CMAs) in the U.K. & Europe

March 27, 2026
·
5 min read
Press Releases

InMed Pharmaceuticals Receives Nasdaq Notification Regarding Minimum Bid Price Compliance

March 27, 2026
·
5 min read
Press Releases

Rubedo Life Sciences Announces Positive Preliminary Phase 1 Clinical Trial Results for Lead Drug Candidate RLS-1496 in Patients with Plaque Psoriasis, Atopic Dermatitis, and Skin Aging

March 27, 2026
·
7 min read
Press Releases

Organon Debuts New Analysis of VTAMA® (tapinarof) cream, 1%, Phase 3 Pooled Data Demonstrating Early and Consistent Skin Clearance and Itch Improvement in Atopic Dermatitis Patients Down to 2 Years of Age

March 27, 2026
·
7 min read